Table 2.
Variable Studied | No. of Studies | Odds Ratio | Q Statistic | I2 statistic, % |
---|---|---|---|---|
Proportion of deceased with HTN | 15/36 | 4.87 | 102.3 | 75.9 |
Proportion of survivors with HTN | 9/36 | 82.1 | 93.8 | |
Proportion of severe COVID-19 with HTN | 18/36 | 3.26 | 202.2 | 93.9 |
Proportion of non-severe COVID-19 with HTN | 14/36 | 830.9 | 98.8 | |
Proportion of deceased with CVD | 14/36 | 6.87 | 204.7 | 89.3 |
Proportion of survivors with CVD | 8/36 | 53.2 | 93.6 | |
Proportion of severe COVID-19 with CVD | 19/36 | 3.16 | 431.3 | 95.8 |
Proportion of non-severe COVID-19 with CVD | 15/36 | 832.9 | 98.9 | |
Proportion of deceased with CBVD | 8/36 | 4.28 | 17.9 | 64.9 |
Proportion of survivors with CBVD | 5/36 | 17.6 | 82.8 | |
Proportion of severe COVID-19 with CBVD | 9/36 | 1.90 | 43.7 | 81.5 |
Proportion of non-severe COVID-19 with CBVD | 7/36 | 22.8 | 84.4 | |
Proportion of deceased with CKD | 11/36 | 8.86 | 104.3 | 83.2 |
Proportion of survivors with CKD | 5/36 | 4.9 | 0.0006 | |
Proportion of severe COVID-19 with CKD | 11/36 | 1.92 | 237.2 | 95.2 |
Proportion of non-severe COVID-19 with CKD | 9/36 | 39.5 | 98.3 |
*Abbreviations used: HTN - hypertension; CVD - cardiovascular disease; CBVD - cerebrovascular disease; CKD - chronic kidney disease.